{"id":"https://openalex.org/W4385688012","doi":"https://doi.org/10.1016/j.clinre.2023.102192","title":"Combination immune checkpoint therapy carried on despite grade 4 immune-related hepatotoxicity during treatment of metastatic melanoma: Case report and review of literature","display_name":"Combination immune checkpoint therapy carried on despite grade 4 immune-related hepatotoxicity during treatment of metastatic melanoma: Case report and review of literature","publication_year":2023,"publication_date":"2023-08-09","ids":{"openalex":"https://openalex.org/W4385688012","doi":"https://doi.org/10.1016/j.clinre.2023.102192","pmid":"https://pubmed.ncbi.nlm.nih.gov/37567465"},"language":"en","primary_location":{"id":"doi:10.1016/j.clinre.2023.102192","doi":"https://doi.org/10.1016/j.clinre.2023.102192","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clinre.2023.102192","pdf_url":"https://www.sciencedirect.com/science/article/am/pii/S2210740123001171","source":{"id":"https://openalex.org/S2481910785","display_name":"Clinics and Research in Hepatology and Gastroenterology","issn_l":"2210-7401","issn":["2210-7401","2210-741X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clinics and Research in Hepatology and Gastroenterology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.sciencedirect.com/science/article/am/pii/S2210740123001171","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5097981640","display_name":"Ang\u00e8le Lallement","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4210143740","display_name":"H\u00f4pital Saint Eloi","ror":"https://ror.org/04pwyfk22","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210143740"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ang\u00e8le Lallement","raw_affiliation_strings":["D\u00e9partement de Dermatologie, CHU Saint-Eloi, Universit\u00e9 de Montpellier, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Dermatologie, CHU Saint-Eloi, Universit\u00e9 de Montpellier, Montpellier, France","institution_ids":["https://openalex.org/I19894307","https://openalex.org/I4210143740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023752998","display_name":"Anouck Lamoureux","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4210143740","display_name":"H\u00f4pital Saint Eloi","ror":"https://ror.org/04pwyfk22","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210143740"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anouck Lamoureux","raw_affiliation_strings":["D\u00e9partement de Dermatologie, CHU Saint-Eloi, Universit\u00e9 de Montpellier, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Dermatologie, CHU Saint-Eloi, Universit\u00e9 de Montpellier, Montpellier, France","institution_ids":["https://openalex.org/I19894307","https://openalex.org/I4210143740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066197793","display_name":"Micha\u00ebl Hummelsberger","orcid":"https://orcid.org/0009-0003-0513-6572","observed_orcids":["https://orcid.org/0009-0003-0513-6572"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Hummelsberger","raw_affiliation_strings":["Service d'oncologie m\u00e9dicale, Clinique St Privat, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service d'oncologie m\u00e9dicale, Clinique St Privat, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069694454","display_name":"Alexandre Thibault Jacques Maria","orcid":"https://orcid.org/0000-0002-0868-5804","observed_orcids":["https://orcid.org/0000-0002-0868-5804"]},"institutions":[{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4210143740","display_name":"H\u00f4pital Saint Eloi","ror":"https://ror.org/04pwyfk22","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210143740"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Alexandre Maria","raw_affiliation_strings":["D\u00e9partement de M\u00e9decine Interne & Immuno-Oncologie (MedI\u00b2O), CHU Saint Eloi, Universit\u00e9 de Montpellier, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de M\u00e9decine Interne & Immuno-Oncologie (MedI\u00b2O), CHU Saint Eloi, Universit\u00e9 de Montpellier, Montpellier, France","institution_ids":["https://openalex.org/I19894307","https://openalex.org/I4210143740"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061151762","display_name":"Lucy Meunier","orcid":"https://orcid.org/0000-0001-5697-286X","observed_orcids":["https://orcid.org/0000-0001-5697-286X"]},"institutions":[{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4210143740","display_name":"H\u00f4pital Saint Eloi","ror":"https://ror.org/04pwyfk22","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210143740"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Lucy Meunier","raw_affiliation_strings":["D\u00e9partement d'H\u00e9pato gastro ent\u00e9rologie et Transplantation, CHU Saint Eloi, Universit\u00e9 de Montpellier, Montpellier, France. Electronic address: Lucy.meunier@chu-montpellier.fr","D\u00e9partement d'H\u00e9pato gastro ent\u00e9rologie et Transplantation, CHU Saint Eloi, Universit\u00e9 de Montpellier, Montpellier, France"],"raw_orcid":"https://orcid.org/0000-0001-5697-286X","affiliations":[{"raw_affiliation_string":"D\u00e9partement d'H\u00e9pato gastro ent\u00e9rologie et Transplantation, CHU Saint Eloi, Universit\u00e9 de Montpellier, Montpellier, France. Electronic address: Lucy.meunier@chu-montpellier.fr","institution_ids":["https://openalex.org/I19894307","https://openalex.org/I4210143740"]},{"raw_affiliation_string":"D\u00e9partement d'H\u00e9pato gastro ent\u00e9rologie et Transplantation, CHU Saint Eloi, Universit\u00e9 de Montpellier, Montpellier, France","institution_ids":["https://openalex.org/I19894307","https://openalex.org/I4210143740"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5061151762"],"corresponding_institution_ids":["https://openalex.org/I19894307","https://openalex.org/I4210143740"],"apc_list":{"value":2760,"currency":"USD","value_usd":2760},"apc_paid":null,"fwci":0.361,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.53919202,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"47","issue":"8","first_page":"102192","last_page":"102192"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.8389999866485596},{"id":"https://openalex.org/keywords/immune-related-hepatitis","display_name":"immune-related hepatitis","score":0.8939999938011169},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8539999723434448},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.8949999809265137},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":1.0},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.8320000171661377},{"id":"https://openalex.org/keywords/corticosteroid-therapy","display_name":"corticosteroid therapy","score":0.8610000014305115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9402487277984619},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.9335616827011108},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.9182990789413452},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8858975172042847},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6166515946388245},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6083334684371948},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5721317529678345},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5210953950881958},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5019931793212891},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.46329841017723083},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4355301260948181},{"id":"https://openalex.org/C2776029263","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Hepatitis","level":2,"score":0.4269421398639679},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.42031028866767883},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4170913100242615},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39320436120033264},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33637046813964844},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.24695521593093872},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.1506444811820984}],"mesh":[{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000074324","descriptor_name":"Ipilimumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000074324","descriptor_name":"Ipilimumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000077594","descriptor_name":"Nivolumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000077594","descriptor_name":"Nivolumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.clinre.2023.102192","doi":"https://doi.org/10.1016/j.clinre.2023.102192","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clinre.2023.102192","pdf_url":"https://www.sciencedirect.com/science/article/am/pii/S2210740123001171","source":{"id":"https://openalex.org/S2481910785","display_name":"Clinics and Research in Hepatology and Gastroenterology","issn_l":"2210-7401","issn":["2210-7401","2210-741X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clinics and Research in Hepatology and Gastroenterology","raw_type":"journal-article"},{"id":"pmid:37567465","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37567465","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinics and research in hepatology and gastroenterology","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-05094884v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-05094884","pdf_url":"https://hal.science/hal-05094884/document","source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinics and Research in Hepatology and Gastroenterology, 2023, 47 (8), pp.102192. ⟨10.1016/j.clinre.2023.102192⟩","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/j.clinre.2023.102192","doi":"https://doi.org/10.1016/j.clinre.2023.102192","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clinre.2023.102192","pdf_url":"https://www.sciencedirect.com/science/article/am/pii/S2210740123001171","source":{"id":"https://openalex.org/S2481910785","display_name":"Clinics and Research in Hepatology and Gastroenterology","issn_l":"2210-7401","issn":["2210-7401","2210-741X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clinics and Research in Hepatology and Gastroenterology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4385688012.pdf","grobid_xml":"https://content.openalex.org/works/W4385688012.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1541193052","https://openalex.org/W2103220202","https://openalex.org/W2105057287","https://openalex.org/W2154441168","https://openalex.org/W2179179825","https://openalex.org/W2746991247","https://openalex.org/W3016806376","https://openalex.org/W3048739245","https://openalex.org/W3083702883","https://openalex.org/W3114253099","https://openalex.org/W3210474759","https://openalex.org/W3213713949","https://openalex.org/W4224984865","https://openalex.org/W4306692674","https://openalex.org/W4316927914","https://openalex.org/W4323308954"],"related_works":["https://openalex.org/W4281386300","https://openalex.org/W3083702883","https://openalex.org/W4387539223","https://openalex.org/W4240947113","https://openalex.org/W4289979515","https://openalex.org/W3186399754","https://openalex.org/W3128367530","https://openalex.org/W3096009481","https://openalex.org/W3199659450","https://openalex.org/W2896022891"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2023-08-10T00:00:00"}